Accretion Pharmaceuticals SME IPO Subscription Status
Accretion Pharmaceuticals SME IPO closed on 16 May 2025 with an overall subscription of 7.67x based on shares applied. QIB demand came in at 12.14x, NII at 4.28x, and retail at 10.44x.
Allotment will be finalised on 19 May 2025. The stock is scheduled to list on NSE and BSE on 21 May 2025.
Issue Price
Rs 101.00
GMP Today
-
Overall Subscription
7.67x
Issue Size
₹29.75 Cr
Allotment Date
19 May 2025
Listing Date
21 May 2025
Accretion Pharmaceuticals SME IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 101.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 1.43 Cr | Rs 17.37 Cr | 12.14x |
| NII | Rs 12.35 Cr | Rs 52.81 Cr | 4.28x |
| IND | Rs 12.35 Cr | Rs 128.94 Cr | 10.44x |
| Total | Rs 26.13 Cr | Rs 199.12 Cr | 7.62x |
Accretion Pharmaceuticals SME IPO Subscription by Shares
Category-wise subscription based on shares bid. Application-wise bid counts are not available for this IPO yet.
| Category | Shares Offered | Shares Bid | Subscription |
|---|---|---|---|
| QIB | 1,41,600 | 17,19,600 | 12.14x |
| NII | 12,22,800 | 52,28,400 | 4.28x |
| IND | 12,22,800 | 1,27,66,800 | 10.44x |
| Total | 25,87,200 | 1,97,14,800 | 7.62x |
What Do These Subscription Numbers Mean?
A subscription of 7.67x by shares means the IPO received bids for 8 times the shares reserved. Allotment odds depend on application count in each category, not share volume.
Here is what each category number tells you:
QIB at 12.14x by shares: This is the strongest signal on the page. QIBs are institutional investors, mutual funds, foreign institutions, and banks. When they subscribe at 12.14x, it reflects serious institutional conviction.
NII at 4.28x by shares: NII includes high net worth individuals applying above Rs 2 lakh. Proportional allotment uses application subscription.
Retail at 10.44x by shares: Allotment is by lottery, but application-wise data is needed for accurate 1-in-X odds. Share oversubscription often overstates how hard allotment is.
Accretion Pharmaceuticals SME IPO Allotment Chances
Allotment odds below use application subscription (number of bids received), not share or amount subscribed.
Retail (IND)
- •Share subscription: 10.44x (application-wise data pending).
- •Allotment odds will be updated once application subscription is synced.
Check the Accretion Pharmaceuticals SME IPO Allotment Status page from 19 May 2025 for your allotment result.
Accretion Pharmaceuticals SME IPO Day-wise Subscription
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 14 May 2025 | 0.00x | 0.51x | 1.86x | 1.12x |
| Day 2 - 15 May 2025 | 0.75x | 0.92x | 4.01x | 2.37x |
| Day 3 - 16 May 2025 | 12.14x | 4.28x | 10.44x | 7.62x |
Accretion Pharmaceuticals SME IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 14 May 2025 |
| IPO Close Date | 16 May 2025 |
| Allotment Date | 19 May 2025 |
| Refund Initiation | 20 May 2025 |
| Share Credit to Demat | 20 May 2025 |
| Listing Date | 21 May 2025 |
| Minimum Investment | Rs 2,42,400.00 |
| Lot Size | 1200 shares |
About Accretion Pharmaceuticals SME
No company information available
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors
High net worth individuals applying above Rs 2 lakh. Divided into bNII (above Rs 10 lakh) and sNII (Rs 2 lakh to Rs 10 lakh). NII allotment is proportional.
IND - Individual Investors
Investors applying up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Minimum one lot per successful applicant.
Accretion Pharmaceuticals SME IPO GMP Today
Live GMP, listing price estimate, and listing gain
Accretion Pharmaceuticals SME IPO Allotment Status
Check allotment result on allotment date
Accretion Pharmaceuticals SME IPO Details
Financials, peers, strengths, and review
All IPO Subscription Status
Subscription for all active IPOs
Accretion Pharmaceuticals SME IPO Subscription FAQs
What is Accretion Pharmaceuticals SME IPO subscription status today?
Accretion Pharmaceuticals SME IPO subscription closed on 16 May 2025 with overall subscription of 7.67x (by shares) as of 27 June 2026, 2:01 AM IST. QIB 12.14x, NII 4.28x, IND 10.44x.
What is the overall subscription of Accretion Pharmaceuticals SME IPO?
Accretion Pharmaceuticals SME IPO is subscribed 7.67x overall by shares at close on 16 May 2025. QIB 12.14x, NII 4.28x, and IND 10.44x.
What is Accretion Pharmaceuticals SME IPO QIB subscription?
Accretion Pharmaceuticals SME IPO QIB (Qualified Institutional Buyers) subscription is 12.14x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Accretion Pharmaceuticals SME IPO IND subscription?
Accretion Pharmaceuticals SME IPO IND subscription is 10.44x by shares. Minimum retail bid is up to Rs 2 lakh per PAN.
What is Accretion Pharmaceuticals SME IPO NII subscription?
Accretion Pharmaceuticals SME IPO NII (Non-Institutional Investors) subscription is 4.28x by shares. NII covers bids above Rs 2 lakh.
What are allotment chances in Accretion Pharmaceuticals SME IPO for retail?
Accretion Pharmaceuticals SME IPO retail share subscription is 10.44x. Application-wise data is needed for accurate lottery odds.
When is Accretion Pharmaceuticals SME IPO allotment date?
Accretion Pharmaceuticals SME IPO allotment date is 19 May 2025. Check Accretion Pharmaceuticals SME IPO Allotment Status on IPOwiz from that day using your PAN.
When does Accretion Pharmaceuticals SME IPO subscription close?
Accretion Pharmaceuticals SME IPO subscription closed on 16 May 2025. No new applications are accepted after the close.
What is Accretion Pharmaceuticals SME IPO GMP today?
GMP for Accretion Pharmaceuticals SME IPO is not available yet. Track Accretion Pharmaceuticals SME IPO GMP Today on IPOwiz once grey market activity starts.
What is Accretion Pharmaceuticals SME IPO issue price and lot size?
Accretion Pharmaceuticals SME IPO issue price is ₹101 per share. Lot size is 1200 shares. Minimum investment is ₹2,42,400 per lot (minimum 2 lots for SME). Issue size: ₹29.75 Cr.
When is Accretion Pharmaceuticals SME IPO listing date?
Accretion Pharmaceuticals SME IPO listing date is 21 May 2025 on NSE and BSE. Allotment is on 19 May 2025.
How does subscription affect Accretion Pharmaceuticals SME IPO allotment?
Allotment odds in Accretion Pharmaceuticals SME IPO depend on application subscription in each category, not share volume. Retail uses lottery when oversubscribed. NII uses proportional allotment by applications. At 7.67x overall, competition is moderate.
For allotment results from 19 May 2025, visit the Accretion Pharmaceuticals SME IPO Allotment Status page. For listing day updates on 21 May 2025, download the IPOwiz App.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. Subscription data verified before publish.